通过连续微流体电穿孔芯片扩大CRISPR/Cas9基因编辑的细胞数量
Zixi Li1, Xinyue Su1, Yihong Lin1
1Department of Biomedical Engineering, School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China.
Bioelectrochemistry (Amsterdam, Netherlands)
|October 30, 2024
概括
一个新的大容量连续电穿孔芯片 (LaViE-Chip) 实现了CRISPR/Cas9基因治疗的高效,大规模的细胞编辑. 这一突破克服了基因编辑技术广泛临床应用的关键障碍.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 生物工程是生物工程.
背景情况:
- 克里斯普尔/卡斯9基因编辑显示了治疗潜力,但由于生产足够数量的编辑细胞的困难而受到限制.
- 基因编辑细胞的高效大规模生产对于CRISPR/Cas9疗法的临床转化至关重要.
研究的目的:
- 为CRISPR/Cas9应用开发一种新的电穿孔系统,以实现高通量,高效和可行的细胞编辑.
- 解决产生足够数量的转基因细胞用于治疗的瓶问题.
主要方法:
- 开发一个大容量连续电穿孔芯片 (LaViE-Chip),使用并行微流体通道和离芯片电极.
- 优化微流体通道设计以实现均的电场,减少电极近距离效应和控制电池旋转.
- 通过电穿孔进行CRISPR/Cas9基因编辑的连续处理演示.
主要成果:
- 该LaViE芯片实现了71.06%的电传输效率和84.3%的细胞活力.
- 实现了10^7细胞/分钟的高细胞处理速度.
- 该系统成功地展示了持续的CRISPR基因编辑,证明了其治疗应用的潜力.
结论:
- 拉维埃芯片显著提高了CRISPR/Cas9介导基因编辑的效率和可扩展性.
- 这项技术克服了生产治疗性基因编辑细胞的关键限制,为临床进步铺平了道路.
- 基于连续电穿孔的基因编辑现在是可行的,为未来的治疗策略奠定了基础.
相关概念视频
CRISPR
60.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.2K
CRISPR/Cas9 Genome Editing
3.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.1K


